It seems like eons ago that David Wright was getting a standing ovation at the All-Star Game at Citi Field and was putting together an MVP-caliber season. But it was less than a month ago when he pulled his hamstring effectively ending his season. Or maybe not quite ending it, as the Star-Ledger reports that he’s about to go off on a rehab assignment in Florida.
He could still get a couple of big league games in at the end of September, but I don’t know what it would accomplish. When the Mets signed him to that extension it was for the long haul. The long haul play here seems to be to exercise caution with their superstar.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.